These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24063967)

  • 1. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
    Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
    Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humeral metastasis of renal cancer: Surgical options and review of literature.
    Casadei R; Drago G; Di Pressa F; Donati D
    Orthop Traumatol Surg Res; 2018 Jun; 104(4):533-538. PubMed ID: 29654934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopaedic management of bony metastases of renal cancer.
    Pongracz N; Zimmerman R; Kotz R
    Semin Surg Oncol; 1988; 4(2):139-42. PubMed ID: 3393777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular endoprosthetic replacement for tumours of the proximal femur.
    Chandrasekar CR; Grimer RJ; Carter SR; Tillman RM; Abudu A; Buckley L
    J Bone Joint Surg Br; 2009 Jan; 91(1):108-12. PubMed ID: 19092014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Is the Prosthetic Survival After Resection and Intercalary Endoprosthetic Reconstruction for Diaphyseal Bone Metastases of the Humerus and Femur?
    Johnson JD; Satcher RL; Feng L; Lewis VO; Moon BS; Bird JE; Lin PP
    Clin Orthop Relat Res; 2023 Nov; 481(11):2200-2210. PubMed ID: 37185204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
    Wroński M; Arbit E; Russo P; Galicich JH
    Urology; 1996 Feb; 47(2):187-93. PubMed ID: 8607231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient survival after surgery for osseous metastases from renal cell carcinoma.
    Lin PP; Mirza AN; Lewis VO; Cannon CP; Tu SM; Tannir NM; Yasko AW
    J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
    Assouad J; Banu E; Brian E; Pham DN; Dujon A; Foucault C; Riquet M
    Eur J Cardiothorac Surg; 2008 May; 33(5):794-8. PubMed ID: 18304831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention.
    Kollender Y; Bickels J; Price WM; Kellar KL; Chen J; Merimsky O; Meller I; Malawer MM
    J Urol; 2000 Nov; 164(5):1505-8. PubMed ID: 11025692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of osseous metastases in patients with renal cell carcinoma.
    Dürr HR; Maier M; Pfahler M; Baur A; Refior HJ
    Clin Orthop Relat Res; 1999 Oct; (367):283-90. PubMed ID: 10546626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of surgery in bone metastases of renal cell carcinoma: 13 case reports].
    Le Mouel S; Gaston A; Paule B
    Prog Urol; 2008 Dec; 18(13):1045-9. PubMed ID: 19041809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures.
    Dijstra S; Wiggers T; van Geel BN; Boxma H
    Eur J Surg; 1994 Oct; 160(10):535-42. PubMed ID: 7849154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and survival of osseous renal cell carcinoma metastases.
    Evenski A; Ramasunder S; Fox W; Mounasamy V; Temple HT
    J Surg Oncol; 2012 Dec; 106(7):850-5. PubMed ID: 22623216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?
    Gutowski CJ; Zmistowski B; Fabbri N; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2019 Apr; 477(4):707-714. PubMed ID: 30811363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma.
    Althausen P; Althausen A; Jennings LC; Mankin HJ
    Cancer; 1997 Sep; 80(6):1103-9. PubMed ID: 9305711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.